MGC Pharma receives first tranche of funding under new $10m financing facility
The financing facility will fund the execution of MGC Pharma’s business commercialisation strategy in the UK and US.
The financing facility will fund the execution of MGC Pharma’s business commercialisation strategy in the UK and US.
MGC Pharmaceuticals has received a Free Trade Certificate in Germany for its product ArtemiC which has shown successful results in treating COVID-19 patients.
The company’s experimental treatment for severe epilepsy will be covered by the health service.
Two medical patients have revealed the role the treatment has played in their lives at an industry conference.
Danish politicians have agreed to extend a medical cannabis programme – and North America’s giants are watching
Canadian company Zyus’ deal to enter Portugal is another indication the global industry is watching Europe
How an Israel-based company made history by listing on the London Stock Exchange
A Canadian firm is trialing a synthetic cannabinoid treatment for a common pet health issue
It has a world famous reputation among cannabis users – but a decades old problem